Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 27% ± 5% | |
ciliated cell | 3 studies | 16% ± 1% |
Insufficient scRNA-seq data for expression of MTRES1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 1380.19 | 258 / 258 | 100% | 25.69 | 230 / 230 |
kidney | 100% | 811.83 | 89 / 89 | 100% | 18.69 | 901 / 901 |
liver | 100% | 678.04 | 226 / 226 | 100% | 17.67 | 406 / 406 |
ovary | 100% | 506.67 | 180 / 180 | 100% | 17.86 | 430 / 430 |
prostate | 100% | 536.75 | 245 / 245 | 100% | 19.51 | 502 / 502 |
thymus | 100% | 741.00 | 653 / 653 | 100% | 26.38 | 605 / 605 |
uterus | 100% | 542.41 | 170 / 170 | 100% | 23.14 | 459 / 459 |
brain | 100% | 701.53 | 2641 / 2642 | 100% | 25.22 | 705 / 705 |
pancreas | 100% | 371.81 | 327 / 328 | 100% | 20.54 | 178 / 178 |
bladder | 100% | 626.10 | 21 / 21 | 100% | 22.01 | 502 / 504 |
breast | 100% | 564.78 | 459 / 459 | 100% | 24.23 | 1113 / 1118 |
intestine | 100% | 813.22 | 966 / 966 | 99% | 21.59 | 523 / 527 |
stomach | 100% | 565.54 | 358 / 359 | 99% | 17.84 | 284 / 286 |
esophagus | 100% | 598.86 | 1445 / 1445 | 99% | 11.82 | 181 / 183 |
skin | 100% | 608.44 | 1808 / 1809 | 99% | 15.78 | 467 / 472 |
lung | 91% | 379.94 | 524 / 578 | 100% | 16.89 | 1154 / 1155 |
adipose | 100% | 571.68 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 20.35 | 29 / 29 |
spleen | 100% | 613.61 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 17.68 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.81 | 1 / 1 |
muscle | 100% | 869.24 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 548.68 | 1331 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 18.35 | 79 / 80 |
heart | 99% | 767.95 | 850 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 47% | 207.96 | 439 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0072344 | Biological process | rescue of stalled ribosome |
GO_1903108 | Biological process | regulation of mitochondrial transcription |
GO_0005739 | Cellular component | mitochondrion |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0043023 | Molecular function | ribosomal large subunit binding |
GO_0000049 | Molecular function | tRNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | MTRES1 |
Protein name | Mitochondrial transcription rescue factor 1 |
Synonyms | C6orf203 HSPC230 |
Description | FUNCTION: Mitochondrial RNA-binding protein involved in mitochondrial transcription regulation. Functions as a protective factor to maintain proper mitochondrial RNA level during stress. Acts at the transcription level and its protective function depends on its RNA binding ability . Part of a mitoribosome-associated quality control pathway that prevents aberrant translation by responding to interruptions during elongation . As heterodimer with MTRF, ejects the unfinished nascent chain and peptidyl transfer RNA (tRNA), respectively, from stalled ribosomes. Recruitment of mitoribosome biogenesis factors to these quality control intermediates suggests additional roles for MTRES1 and MTRF during mitoribosome rescue . . |
Accessions | ENST00000625458.1 A0A0D9SEI0 ENST00000311381.8 Q9P0P8 ENST00000405204.6 |